Tumas Beinortas

Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study

Kazimieras Maneikis, Karolis Šablauskas, Ugnė Ringelevičiūtė et al. · The Lancet Haematology · 2021 · 242 citations · Full text

Vaccination, Vaccine Safety, Vaccinology +8

MYC Drives <i>Pten/Trp53</i> -Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2

Dawid G. Nowak, Hyejin Cho, Tali Herzka et al. · Cancer Discovery · 2015 · 77 citations · Full text

In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesis

David Lara‐Astiaso, Ainhoa Goñi‐Salaverri, Julen Mendieta-Esteban et al. · Nature Genetics · 2023 · 47 citations · Full text

Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study

Catherine Cargo, Elsa Bernard, Tumas Beinortas et al. · The Lancet Haematology · 2023 · 25 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +11

Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000–2013

Tumas Beinortas, Ilma Tavorienė, Tadas Žvirblis et al. · BMC Cancer · 2016 · 23 citations · Full text